Last updated on December 2019

Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II IIIA and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)


Find a site near you

Start Over

Wits Clinical Research ( Site 0570)

Parktown-Johannesburg, South Africa
  Connect »